Heart Failure
Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Information is based on current medical literature and clinical guidelines but may not apply to your specific situation. Individual responses vary based on personal medical history and concurrent conditions. Always consult qualified healthcare providers before starting new treatments and for all medical decisions. Never delay seeking medical care based on content you have read.
These articles provide education to enhance your healthcare partnership. All treatment decisions should involve your healthcare team. Use this knowledge to have informed discussions, not replace medical care.
In Brief
Heart failure is rarely the start of the problem; it is usually the culmination of one. By the time a person first feels breathless climbing the stairs, the heart has usually been under strain for years — quietly injured by a heart attack, worn down by high blood pressure, overloaded by a failing valve, stressed by diabetes, or altered by a disease of the muscle itself. Each of these causes injures the heart in a recognizable way, and each accumulates its damage silently, long before symptoms arrive. That silent period is also an opportunity: because the injury builds slowly, there is often a long window in which the process can be interrupted — coronary disease treated, blood pressure controlled, a diseased valve repaired or replaced at the appropriate time, an arrhythmia treated, or a specific cardiomyopathy identified and addressed. This article traces the main routes into heart failure, how each one damages the heart over time, and why catching the process early can slow, and sometimes partly reverse, damage that would otherwise become permanent. Most heart failure develops this way, slowly; but it can also worsen or arise abruptly — a medical emergency — which this article returns to near the end.
The Damage Comes First, the Symptoms Come Later
The most important thing to understand about how heart failure usually develops is also the least intuitive: the disease is typically well underway before any symptoms appear. Most heart failure follows this slow pattern; but it can also worsen or appear abruptly, and this article turns to that near the end.
The organizations that define heart failure describe it as a process that moves through stages — beginning long before symptoms. A person can be simply at risk (having high blood pressure or diabetes but a structurally normal heart), then progress to pre-heart-failure (measurable changes in the heart’s structure or function, still without symptoms), and only later to symptomatic heart failure.[2][3] The first two stages produce no breathlessness and no swelling. They are silent by definition. And they are common: a large share of the adult population sits in one of these at-risk or pre-symptomatic categories without knowing it.[1]
This matters because it reframes the whole question. The moment of diagnosis feels like the start of the problem, but it is usually the point at which a long, silent process finally produced noticeable symptoms. The heart injury that produces symptoms has typically been accumulating for years.[1] Understanding the routes that lead there is not academic — it is how the process can be caught while it is still silent, when there is the most to gain.
Broadly, the heart can be injured in a few distinct ways: it can lose muscle (a heart attack), be forced to work against too much pressure (high blood pressure, a stiff valve), be forced to handle too much volume (a leaky valve), be damaged directly at the level of the muscle (the cardiomyopathies), or be worn down by the metabolic stress of diabetes. Most patients have more than one of these processes at once. Here is each in turn.
Coronary Artery Disease and Heart Attack
In high-income countries, the most common route into heart failure runs through the coronary arteries — the vessels that supply the heart muscle itself with blood.[1]
Over years, these arteries can narrow with atherosclerosis (fatty plaque buildup in the artery wall). When a plaque ruptures and a clot blocks the artery, the muscle downstream is suddenly starved of oxygen — a myocardial infarction, or heart attack. Muscle that loses its blood supply for long enough dies, and dead heart muscle does not grow back. It is replaced by scar (stiff, fibrous tissue that cannot contract). A heart that has lost a region of its pumping muscle to scar is weakened, and if enough is lost, it can no longer eject blood normally — a condition called ischemic cardiomyopathy(heart muscle weakened by inadequate blood supply). This is a leading cause of the reduced-ejection-fraction heart failure described in Article 2.
Coronary disease can also contribute to progressive weakening of the heart without a single large heart attack, as areas of muscle are left chronically underperfused — alive, but contracting poorly. Treating the coronary disease remains important, but whether restoring blood flow improves the heart’s function or a person’s outcomes depends on the coronary anatomy, the symptoms, how much damage has already occurred, and the individual clinical situation. Some dysfunctional muscle may recover after blood flow is restored, but recovery is not guaranteed, and these decisions are not based on the ejection fraction alone.[3] Permanent scar cannot be undone — but preventing the heart attack in the first place, by treating the coronary disease early, prevents the scar entirely.
Long-Standing High Blood Pressure
High blood pressure contributes to heart failure silently, and it is among the most preventable causes.
Blood pressure is the resistance the heart pumps against. When it stays high for years, the left ventricle faces a permanent uphill push, called pressure overload. Like any muscle asked to work harder, it responds by thickening — a change called hypertrophy (thickening of the muscle wall). For a while, a thicker wall helps. But a thickened ventricle gradually becomes stiff, and a stiff chamber cannot relax and fill properly — the mechanism behind much of preserved-ejection-fraction heart failure from Article 2. In some people, prolonged high blood pressure also contributes to ventricular dilation and a weakened squeeze. High blood pressure can therefore contribute to both preserved- and reduced-ejection-fraction heart failure, though the pathways are not identical in every person — and it does so without causing symptoms along the way.
The encouraging part is how much of this is preventable. Controlling blood pressure is one of the best-proven ways to prevent heart failure from ever developing: in a large trial, treating blood pressure to a lower target substantially reduced the risk of new heart failure compared with a standard target.[4] Sustained blood-pressure control can also, over time, partly reverse the wall thickening it caused. The damage from hypertension is slow and silent, and, caught in time, among the more reversible causes of heart failure.
Valve Disease
The heart has four valves — one-way doors that keep blood moving in the right direction. When a valve fails, it fails in one of two ways, and each overloads the heart differently.[6]
A valve can become stenotic — narrowed and stiff, so the heart must strain to push blood through a smaller opening. The most important example is aortic stenosis, a narrowing of the valve between the left ventricle and the body’s main artery, which forces the ventricle into the same kind of pressure overload as high blood pressure. A valve can also become regurgitant — leaky, so that blood sloshes backward with each beat and the heart must pump the same blood twice. This creates volume overload, and over time the chamber stretches and enlarges to cope. Either pattern, sustained for years, wears the heart down into failure.
Valve disease is fundamentally a mechanical problem, but deciding when — and whether — to intervene requires more than finding a narrowed or leaky valve. The severity of the lesion, its cause, the symptoms, how the ventricle and the lung pressures have responded, and the risk of the procedure itself all matter — and not all leakage is a primary valve problem, since sometimes a valve leaks because the ventricle behind it is failing. For the right patient, though, repair or replacement at the appropriate time — surgically or, increasingly, through catheter-based procedures that avoid open-heart surgery — can unload the heart, improve symptoms, and prevent or limit irreversible damage to the muscle.[6] Timing matters, which is why valve problems are monitored closely once found.
One caution belongs here. Aortic stenosis can be silent for years and then announce itself with warning symptoms — fainting or near-fainting (especially with exertion), chest tightness, or breathlessness. Those symptoms in someone with a known narrowed valve are not to be waited out; they signal that the heart is struggling and need prompt medical evaluation.
Diabetes and the Cardiometabolic Road
Diabetes reaches the heart by more than one path, which is why this series treats diabetes and heart failure as one connected problem rather than two separate diseases.
The first path is indirect: diabetes accelerates the coronary artery disease described above, making heart attacks more likely and more severe. The second path is direct. Chronically high blood sugar, along with the insulin resistance and inflammation that accompany diabetes, can injure the heart muscle itself — stiffening it, scarring it, and impairing both its filling and its pumping — even without a heart attack or significant coronary blockage. Researchers use the term diabetic cardiomyopathy for this: myocardial dysfunction associated with diabetes that cannot be explained solely by coronary disease, high blood pressure, or valve disease.[5] In real patients, however, these processes frequently overlap — diabetes rarely travels alone — which is one reason people with diabetes can develop heart failure without an obvious blocked artery.
The through-line is that the same cardiometabolic forces — high blood sugar, high blood pressure, excess weight, and inflammation — act on the same heart. Addressing them is both diabetes care and heart-failure prevention, and several of the medications that now protect the heart came directly out of diabetes research, a crossover Article 11 explores in depth.
Disease of the Heart Muscle Itself: The Cardiomyopathies
Sometimes the problem is not the arteries, the pressure, or the valves, but the heart muscle itself. Cardiomyopathymeans, literally, disease of the heart muscle — a group of conditions in which the muscle is structurally or functionally abnormal for reasons other than blocked arteries, high blood pressure, or valve disease.[7]
The cardiomyopathies come in several patterns. In dilated cardiomyopathy, the main chamber stretches thin, enlarges, and pumps weakly. In hypertrophic cardiomyopathy, the muscle grows abnormally thick, often from an inherited genetic change. In restrictive or infiltrative forms, the muscle becomes stiff — sometimes because an abnormal substance is depositing within it. The causes are varied: inherited genetic mutations, viral infection of the heart muscle (myocarditis), heavy long-term alcohol use, certain chemotherapy drugs, the strain of pregnancy (peripartum cardiomyopathy), a persistently fast heart rhythm (tachycardia-induced cardiomyopathy), and the buildup of abnormal proteins (cardiac amyloidosis), among others.[7]
Identifying the specific cause matters, because some of these forms are among the more reversible in cardiology. Several cardiomyopathies improve, and sometimes recover substantially, when their cause is removed or treated: a heart weakened by alcohol may improve with sustained abstinence; a heart weakened by a chronically racing rhythm can recover when the rhythm is controlled; and ventricular function improves substantially in many people with peripartum cardiomyopathy, although recovery is variable and some are left with persistent, severe dysfunction.[7] Some causes now have targeted treatments that did not exist a decade ago — cardiac amyloidosis from the protein transthyretin, once untreatable, can now be slowed with a drug that stabilizes that protein, reducing deaths and hospitalizations.[8] And because several cardiomyopathies are inherited, finding one in a patient can prompt screening of relatives, catching the disease in family members while it is still silent.[7] This is why a diagnosis of “cardiomyopathy” is a starting point rather than a conclusion: the next question — which kind, and why — often determines whether the course can be changed.
Rhythm disorders deserve a mention of their own here, because they are among the clearest examples of a reversible cause. A sustained fast or irregular heartbeat — most often atrial fibrillation with a rapid rate, but also other fast rhythms, and in some people a very high burden of extra beats (premature ventricular contractions) — can weaken the pumping chamber over time, a condition called arrhythmia-induced cardiomyopathy. Its defining feature is that controlling the rhythm often reverses much of the damage: in people with atrial fibrillation and a weakened heart, restoring a normal rhythm improves the ejection fraction in a majority. Recovery is not always complete, and it can be hard to tell a rhythm that caused the weakness from one that merely accompanies it — but the possibility is worth pursuing, because when the rhythm is the cause, the heart can substantially recover.[7]
Why Catching It Early Matters
Across all these causes, a single principle applies. Each injures the heart gradually, through a phase in which the damage is real but not yet felt — and in that phase, the process can often be interrupted.
| The cause | How it injures the heart | What can change the course |
| Coronary disease / heart attack | Starves and scars pumping muscle | Prevent and treat coronary disease; revascularization may help in selected situations, though recovery of function is not guaranteed |
| High blood pressure | Pressure overload; the wall thickens and stiffens, and in some people the pump later weakens | Control blood pressure early; a thickened wall can regress |
| Valve disease | Pressure or volume overload wears the chamber down | Repair or replace the valve at the appropriate time, for the right patient |
| Diabetes | Accelerates coronary disease and directly injures the muscle | Manage diabetes and the accompanying cardiovascular and kidney risks; use therapies with proven cardiovascular or heart-failure benefit when appropriate |
| Cardiomyopathies | Direct disease of the muscle, from many causes | Treat the specific cause; some forms recover substantially; screen relatives |
| Sustained arrhythmia | A fast or irregular rhythm can weaken the pump over time | Control the rhythm or rate; the weakening is often substantially reversible |
The limits matter too. Not all injury is reversible. Scar tissue from a completed heart attack does not return to muscle, and a heart remodeled over decades may not fully recover. But the timing of intervention has a large influence. The years before symptoms appear offer a major opportunity for prevention, because some causes can be treated before substantial irreversible damage develops. The opportunity does not end at diagnosis, though: once heart failure is present, modern treatment can still improve symptoms, reduce hospitalizations, lengthen life in appropriate patients, and sometimes help the heart recover some of its function.
When Heart Failure Comes On or Worsens Suddenly
Heart failure can also worsen abruptly. Most often, this is an acute decompensation of heart failure that already exists: the person’s heart is not newly damaged, but tips out of balance — pushed over by something like a chest infection, a spell of ischemia, an arrhythmia, uncontrolled blood pressure, worsening kidney function, or a break in treatment. Less commonly, a new cardiac catastrophe causes heart failure suddenly in a heart that had been coping: a large or mechanically complicated heart attack (for example, a torn papillary muscle causing sudden, severe leakage of the mitral valve), acute severe failure of a valve — such as ruptured mitral cords, from valve degeneration, infection, or injury[6] — or fulminant myocarditis, a severe inflammation of the heart muscle.
In either situation, things can change fast: fluid can accumulate rapidly in the lungs (flash pulmonary edema), and blood pressure can rise sharply or fall dangerously. This is a medical emergency. Sudden, severe breathlessness — especially at rest or when lying flat, or with chest pain or faintness — is a reason to call emergency services immediately, not to wait and watch. Acute heart failure is treated urgently in hospital, and when a new structural problem is the cause, that often needs prompt repair.
Clinical Bottom Line
Heart failure is usually the result of a long, gradual process rather than a sudden event. It develops through identifiable causes — coronary artery disease and heart attack, long-standing high blood pressure, valve disease, diabetes, and diseases of the heart muscle itself — each injuring the heart in its own way, and each accumulating damage silently for years before symptoms appear. That silence is the reason so much heart failure is preventable: caught in the at-risk or pre-symptomatic phase, the underlying cause can often be treated, and some of the injury slowed or partly reversed. Permanent scar cannot be undone, but a great deal of what leads to it can be interrupted — and the earlier, the better. Knowing your own risk factors is the first step in preventing that process.
What Comes Next
This article traced how the heart becomes damaged. Article 4 turns to what that damage feels like: the symptoms of heart failure — breathlessness, swelling, fatigue, weight gain — how clinicians classify severity and stage, and why the same diagnosis can mean very different things for two different people. Learning your own early pattern is more useful than any general list.
Key Terms
Atherosclerosis: Fatty plaque buildup in the walls of arteries, the underlying process of coronary artery disease.
Coronary artery disease: Narrowing of the arteries that supply the heart muscle with blood.
Ischemia: Inadequate blood supply to a tissue; when it affects the heart muscle, it can injure or kill it.
Myocardial infarction (heart attack): Death of a region of heart muscle caused by a sudden loss of its blood supply, usually from a clot in a coronary artery.
Myocardium: The heart muscle.
Scar (fibrosis): Stiff, fibrous tissue that replaces dead or injured muscle; it cannot contract.
Ischemic cardiomyopathy: Heart muscle weakened by inadequate blood supply, typically after one or more heart attacks.
Pressure overload: The strain on the heart when it must pump against high resistance, as in high blood pressure or a narrowed (stenotic) valve.
Volume overload: The strain on the heart when it must handle excess blood volume, as when a leaky (regurgitant) valve makes it pump the same blood repeatedly.
Hypertrophy: Thickening or enlargement of the heart muscle, often an early response to pressure overload; over time it can lead to stiffening.
Aortic stenosis: Narrowing of the valve between the left ventricle and the body’s main artery, forcing the heart to strain against a smaller opening.
Regurgitation: Backward leakage of blood through a valve that no longer closes properly.
Cardiomyopathy: Disease of the heart muscle itself, distinct from problems caused by blocked arteries, high blood pressure, or valve disease.
Dilated cardiomyopathy: A form in which the main chamber enlarges, thins, and pumps weakly.
Hypertrophic cardiomyopathy: A form, often inherited, in which the heart muscle grows abnormally thick.
Myocarditis: Inflammation of the heart muscle, often from a viral infection, which can injure the pump.
Peripartum cardiomyopathy: Heart muscle weakness that develops late in pregnancy or in the months after delivery; many cases recover.
Tachycardia-induced cardiomyopathy: Heart muscle weakness caused by a persistently fast heart rhythm; often reversible when the rhythm is controlled.
Arrhythmia-induced cardiomyopathy: Weakening of the heart’s pumping caused by a sustained abnormal rhythm — such as atrial fibrillation with a fast rate, or a very high burden of extra beats — that is often substantially reversible when the rhythm is controlled. Tachycardia-induced cardiomyopathy is one form.
Cardiac amyloidosis: A form of infiltrative cardiomyopathy in which abnormal proteins deposit in and stiffen the heart muscle; certain types are now treatable.
Diabetic cardiomyopathy: Injury to the heart muscle from diabetes itself, occurring independent of blocked arteries, high blood pressure, or valve disease.
Acute heart failure: A rapid onset or worsening of heart failure that needs urgent care — most often a sudden decompensation of existing heart failure, and less often new heart failure from an abrupt cardiac injury.
Flash pulmonary edema: A rapid flooding of the lungs with fluid that causes severe breathlessness; a hallmark of acute heart failure.
Stages of heart failure (A–D): A framework describing progression from at-risk (A) and pre-heart-failure (B), both silent, through symptomatic (C) and advanced (D) disease.
References
- Fonarow GC, Ahmad FS, Ahmad T, et al. HF Stats 2025: Heart Failure Epidemiology and Outcomes Statistics — An Updated 2025 Report from the Heart Failure Society of America. J Card Fail. 2025. https://doi.org/10.1016/j.cardfail.2025.07.007
- Walsh MN, Kober L, Sliwa K, et al. AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026). Circulation. 2026;153. https://doi.org/10.1161/CIR.0000000000001455
- Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145:e895–e1032. https://doi.org/10.1161/CIR.0000000000001063
- The SPRINT Research Group. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2015;373(22):2103–2116. https://doi.org/10.1056/NEJMoa1511939
- Dunlay SM, Givertz MM, Aguilar D, et al. Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement from the American Heart Association and the Heart Failure Society of America. Circulation. 2019;140(7):e294–e324. https://doi.org/10.1161/CIR.0000000000000691
- Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143:e72–e227. https://doi.org/10.1161/CIR.0000000000000923
- Arbelo E, Protonotarios A, Gimeno JR, et al. 2023 ESC Guidelines for the Management of Cardiomyopathies. Eur Heart J. 2023;44(37):3503–3626. https://doi.org/10.1093/eurheartj/ehad194
- Maurer MS, Schwartz JH, Gundapaneni B, et al. Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-ACT). N Engl J Med. 2018;379(11):1007–1016. https://doi.org/10.1056/NEJMoa1805689
HeartBuddi • Your heart. Own it.